TSXV:CLAS.H - Post by User
Post by
indaknownewfieon May 27, 2020 4:27pm
253 Views
Post# 31079892
Word about Beetlebung Pharma
Word about Beetlebung Pharma So they already have a patent for the glycine3 receptor but their second patent is just as exciting. That covers simplified chemical synthesis of CBD, CBDV, THC, THCV, CBG, CBN, CBC, HU-308 and any derivatives thereof. If you read through the patent application, because it was synthetic they are able to replicate very strong yields of each of these cannabinoids.
Lets not forget that Kaly will automatically get three US patents for the use of injectable nitric oxide. Nitric oxide being tested in three major clinical trials , one 470 people, one 120 people, and a third smaller. All covid patients. Nitric oxide is already FDA approved for other indications so if these trials are succesful, it will be monetized quickly. The trials are for nitric oxide gas through inhalation but our patent is an injectable form that is superior to that and is time released evenly over 48 hrs.